Samuel Isaly, Orbimed Advisors Lower Position in NxStage Medical

Published on November 12, 2013 at 4:23 pm by Alexandr Oleinic in Hedge Funds, News

Samuel Isaly‘s hedge fund, Orbimed Advisors, decreased its stake in NxStage Medical, Inc. (NASDAQ:NXTM) to around 2.89 million shares, from 3.14 million held earlier. Following the decline in holdings, Orbimed’s position amasses 4.73% of NxStage’s common stock, versus 5.25% reported in an earlier filing.

NxStage Medical, Inc. (NASDAQ:NXTM)

Disclosure: none

Samuel Isaly, Orbimed Advisors Lower Position in NxStage Medical

Published on November 12, 2013 at 4:23 pm by Alexandr Oleinic in Hedge Funds, News

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on May 16, 2026 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

Wall Street calls this $3 stock a “Melting Ice Cube.” They said the same thing about BTI before it returned 90%.

Published on May 15, 2026 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

Share

Share

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on May 16, 2026 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

Wall Street calls this $3 stock a “Melting Ice Cube.” They said the same thing about BTI before it returned 90%.

Published on May 15, 2026 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up: